1
|
Omura N, Taguchi A, Kuwahara T, Hamada K, Watanabe M, Nakakuki M, Konno S, Takayama K, Taniguchi A, Nomura T, Shuto S, Hayashi Y. Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity. ACS Med Chem Lett 2023; 14:1807-1814. [PMID: 38116427 PMCID: PMC10726446 DOI: 10.1021/acsmedchemlett.3c00424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 11/20/2023] [Accepted: 11/29/2023] [Indexed: 12/21/2023] Open
Abstract
(+)-Negamycin, which is a dipeptide-like antibiotic containing a hydrazide structure, exhibits readthrough activity, resulting in the restoration of dystrophin in the mdx mouse model of Duchenne muscular dystrophy (DMD). In our previous structure-activity relationship study of negamycin, we found that its natural analogue 3-epi-deoxynegamycin (TCP-107), without antimicrobial activity, showed a higher readthrough activity than negamycin. In this study, we designed and synthesized cyclopropane-based conformationally restricted derivatives of TCP-107 and evaluated their readthrough activity in the cell-based reporter assay against a TGA-type mutation derived from DMD. As a result, a down-cis isomer, TCP-304, showed significant readthrough activity among the four isomers. Moreover, TCP-306, a derivative acylated by l-α-aminoundecanoic acid, possessed approximately 3 times higher activity than TCP-304. These down-cis derivatives showed dose-dependent readthrough activity and were effective for not only TGA but also TAG mutations. These results suggest that the conformational restriction of negamycin derivatives by the introduction of the cyclopropane ring is effective for an exhibition of potent readthrough activity.
Collapse
Affiliation(s)
- Noriko Omura
- Department
of Medicinal Chemistry, Tokyo University
of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| | - Akihiro Taguchi
- Department
of Medicinal Chemistry, Tokyo University
of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| | - Tomoki Kuwahara
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan
| | - Keisuke Hamada
- Department
of Medicinal Chemistry, Tokyo University
of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| | - Mizuki Watanabe
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan
| | - Masanori Nakakuki
- Research
Center, Mochida Pharmaceutical Co., Ltd., 722 Jimba-aza-Uenohara, Gotemba, Shizuoka 412-8524, Japan
| | - Sho Konno
- Department
of Medicinal Chemistry, Tokyo University
of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| | - Kentaro Takayama
- Department
of Medicinal Chemistry, Tokyo University
of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| | - Atsuhiko Taniguchi
- Department
of Medicinal Chemistry, Tokyo University
of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| | - Toshifumi Nomura
- Department
of Dermatology, Hokkaido University Graduate
School of Medicine, North
15 West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan
- Department
of Dermatology, Institute of Medicine, University
of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
| | - Satoshi Shuto
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan
| | - Yoshio Hayashi
- Department
of Medicinal Chemistry, Tokyo University
of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| |
Collapse
|
2
|
Nagata M, Watanabe M, Doi R, Uemura M, Ochiai N, Ichinose W, Fujiwara K, Sato Y, Kameda T, Takeuchi K, Shuto S. Helix-forming aliphatic homo-δ-peptide foldamers based on the conformational restriction effects of cyclopropane. Org Biomol Chem 2023; 21:970-980. [PMID: 36426637 DOI: 10.1039/d2ob01715f] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Considerable effort has been directed toward developing artificial peptide-based foldamers. However, detailed structural analysis of δ-peptide foldamers consisting of only aliphatic δ-amino acids has not been reported. Herein, we rationally designed and stereoselectively synthesized aliphatic homo-δ-peptides forming a stable helical structure by using a chiral cyclopropane δ-amino acid as a monomer unit. Structural analysis of the homo-δ-peptides using circular dichroism, infrared, and NMR spectroscopy indicated that they form a stable 14-helical structure in solution. Furthermore, we successfully conducted X-ray crystallographic analysis of the homo-δ-peptides, demonstrating a right-handed 14-helical structure. This helical structure of the crystal was consistent with those predicted by theoretical calculations and those obtained based on NMR spectroscopy in solution. This stable helical structure is due to the effective restriction of the backbone conformation by the structural characteristics of cyclopropane. This work reports the first example of aliphatic homo-δ-peptide foldamers having a stable helical structure both in the solution and crystal states.
Collapse
Affiliation(s)
- Makoto Nagata
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Mizuki Watanabe
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Ryohei Doi
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Mai Uemura
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Nanase Ochiai
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Wataru Ichinose
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Koichi Fujiwara
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Yoshihiro Sato
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Tomoshi Kameda
- Artificial Intelligence Research Center, National Institute of Advanced Industrial Science and Technology (AIST), 2-4-7 Aomi, Koto-ku, Tokyo 135-0064, Japan
| | - Koh Takeuchi
- Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| |
Collapse
|
3
|
Schaus L, Das A, Knight AM, Jimenez-Osés G, Houk KN, Garcia-Borràs M, Arnold FH, Huang X. Protoglobin-Catalyzed Formation of cis-Trifluoromethyl-Substituted Cyclopropanes by Carbene Transfer. Angew Chem Int Ed Engl 2023; 62:e202208936. [PMID: 36533936 PMCID: PMC9894577 DOI: 10.1002/anie.202208936] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2022] [Indexed: 12/23/2022]
Abstract
Trifluoromethyl-substituted cyclopropanes (CF3 -CPAs) constitute an important class of compounds for drug discovery. While several methods have been developed for synthesis of trans-CF3 -CPAs, stereoselective production of corresponding cis-diastereomers remains a formidable challenge. We report a biocatalyst for diastereo- and enantio-selective synthesis of cis-CF3 -CPAs with activity on a variety of alkenes. We found that an engineered protoglobin from Aeropyrnum pernix (ApePgb) can catalyze this unusual reaction at preparative scale with low-to-excellent yield (6-55 %) and enantioselectivity (17-99 % ee), depending on the substrate. Computational studies revealed that the steric environment in the active site of the protoglobin forced iron-carbenoid and substrates to adopt a pro-cis near-attack conformation. This work demonstrates the capability of enzyme catalysts to tackle challenging chemistry problems and provides a powerful means to expand the structural diversity of CF3 -CPAs for drug discovery.
Collapse
Affiliation(s)
- Lucas Schaus
- Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E California Blvd., Pasadena, CA 91125, USA
| | - Anuvab Das
- Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E California Blvd., Pasadena, CA 91125, USA
| | - Anders M Knight
- Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E California Blvd., Pasadena, CA 91125, USA
| | - Gonzalo Jimenez-Osés
- Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 800, 48160, Derio, Spain
- Ikerbasque, Basque Foundation for Science, 48013, Bilbao, Spain
| | - K N Houk
- Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, USA
| | - Marc Garcia-Borràs
- Institut de Química Computacional i Catàlisi and Departament de Química, Universitat de Girona, C/M. Aurèlia Capmany, 69, 17003, Girona, Spain
| | - Frances H Arnold
- Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E California Blvd., Pasadena, CA 91125, USA
| | - Xiongyi Huang
- Department of Chemistry, Johns-Hopkins University, Baltimore, MD 21218, USA
| |
Collapse
|
4
|
Schaus L, Das A, Knight AM, Jimenez‐Osés G, Houk KN, Garcia‐Borràs M, Arnold FH, Huang X. Protoglobin‐Catalyzed Formation of
cis
‐Trifluoromethyl‐Substituted Cyclopropanes by Carbene Transfer. Angew Chem Int Ed Engl 2022. [DOI: 10.1002/ange.202208936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Lucas Schaus
- Division of Chemistry and Chemical Engineering California Institute of Technology 1200 E California Blvd. Pasadena CA 91125 USA
| | - Anuvab Das
- Division of Chemistry and Chemical Engineering California Institute of Technology 1200 E California Blvd. Pasadena CA 91125 USA
| | - Anders M. Knight
- Division of Chemistry and Chemical Engineering California Institute of Technology 1200 E California Blvd. Pasadena CA 91125 USA
| | - Gonzalo Jimenez‐Osés
- Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Bizkaia Technology Park, Building 800 48160 Derio Spain
- Ikerbasque, Basque Foundation for Science 48013 Bilbao Spain
| | - K. N. Houk
- Department of Chemistry and Biochemistry University of California Los Angeles CA 90095 USA
| | - Marc Garcia‐Borràs
- Institut de Química Computacional i Catàlisi and Departament de Química Universitat de Girona C/M. Aurèlia Capmany, 69 17003 Girona Spain
| | - Frances H. Arnold
- Division of Chemistry and Chemical Engineering California Institute of Technology 1200 E California Blvd. Pasadena CA 91125 USA
| | - Xiongyi Huang
- Department of Chemistry Johns-Hopkins University Baltimore MD 21218 USA
| |
Collapse
|
5
|
Bhosale VA, Císařová I, Kamlar M, Veselý J. Catalytic asymmetric addition to cyclic N-acyl-iminium: access to sulfone-bearing contiguous quaternary stereocenters. Chem Commun (Camb) 2022; 58:9942-9945. [PMID: 35983733 DOI: 10.1039/d2cc02667h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Herein, we report the first chiral phosphoric acid (CPA)-catalyzed asymmetric addition of α-fluoro(phenylsulfonyl)methane (FSM) derivatives to in situ generated cyclic N-acyliminium. This process enables metal-free expeditious access to sulfone and fluorine incorporating contiguous all substituted quaternary stereocenters ingrained in biorelevant isoindolinones in excellent stereoselectivities (up to 99% ee and up to 50 : 1 dr).
Collapse
Affiliation(s)
- Viraj A Bhosale
- Department of Organic Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic.
| | - Ivana Císařová
- Department of Inorganic Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic
| | - Martin Kamlar
- Department of Organic Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic.
| | - Jan Veselý
- Department of Organic Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic.
| |
Collapse
|
6
|
Ishimura K, Fukuda H, Fujiwara K, Muromoto R, Hirashima K, Murakami Y, Watanabe M, Ishihara J, Matsuda T, Shuto S. Synthesis of Resolvin E1 and Its Conformationally Restricted Cyclopropane Congeners with Potent Anti-Inflammatory Effect. ACS Med Chem Lett 2021; 12:256-261. [PMID: 33603972 DOI: 10.1021/acsmedchemlett.0c00639] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Accepted: 01/19/2021] [Indexed: 12/31/2022] Open
Abstract
RvE1 (1) is an endogenous lipid mediator with very potent anti-inflammatory activity, which is due to the inhibition of neutrophil chemotaxis and inflammatory cytokine production and the promotion of macrophage phagocytosis. On the basis of the conformational analysis of RvE1, we designed its four cyclopropane congeners (2a-d), in which the conformationally flexible terminal C1-C4 moiety of RvE1 was rigidified by introducing stereoisomeric cyclopropanes. The four congeners and also RvE1 were efficiently synthesized via a common synthetic route. The evaluation of the anti-inflammatory effects of the compounds in mice resulted in the identification of trans-β-CP-RvE1 (2d), which was significantly more active than RvE1, as a potential lead for anti-inflammatory drugs of a novel mechanism of action.
Collapse
Affiliation(s)
| | - Hayato Fukuda
- Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan
| | | | | | | | | | | | - Jun Ishihara
- Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan
| | | | | |
Collapse
|
7
|
Bhagat K, Singh JV, Pagare PP, Kumar N, Sharma A, Kaur G, Kinarivala N, Gandu S, Singh H, Sharma S, Bedi PMS. Rational approaches for the design of various GABA modulators and their clinical progression. Mol Divers 2021; 25:551-601. [PMID: 32170466 PMCID: PMC8422677 DOI: 10.1007/s11030-020-10068-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2019] [Accepted: 02/28/2020] [Indexed: 12/20/2022]
Abstract
GABA (γ-amino butyric acid) is an important inhibitory neurotransmitter in the central nervous system. Attenuation of GABAergic neurotransmission plays an important role in the etiology of several neurological disorders including epilepsy, Alzheimer's disease, Huntington's chorea, migraine, Parkinson's disease, neuropathic pain, and depression. Increase in the GABAergic activity may be achieved through direct agonism at the GABAA receptors, inhibition of enzymatic breakdown of GABA, or by inhibition of the GABA transport proteins (GATs). These functionalities make GABA receptor modulators and GATs attractive drug targets in brain disorders associated with decreased GABA activity. There have been several reports of development of GABA modulators (GABA receptors, GABA transporters, and GABAergic enzyme inhibitors) in the past decade. Therefore, the focus of the present review is to provide an overview on various design strategies and synthetic approaches toward developing GABA modulators. Furthermore, mechanistic insights, structure-activity relationships, and molecular modeling inputs for the biologically active derivatives have also been discussed. Summary of the advances made over the past few years in the clinical translation and development of GABA receptor modulators is also provided. This compilation will be of great interest to the researchers working in the field of neuroscience. From the light of detailed literature, it can be concluded that numerous molecules have displayed significant results and their promising potential, clearly placing them ahead as potential future drug candidates.
Collapse
Affiliation(s)
- Kavita Bhagat
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, PB, 143005, India
| | - Jatinder V Singh
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, PB, 143005, India
| | - Piyusha P Pagare
- Department of Medicinal Chemistry, School of Pharmacy and Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, 23219, USA
| | - Nitish Kumar
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, PB, 143005, India
| | - Anchal Sharma
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, PB, 143005, India
| | - Gurinder Kaur
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, PB, 143005, India
| | - Nihar Kinarivala
- Program in Chemical Biology, Sloan Kettering Institute, New York, NY, 10065, USA
| | - Srinivasa Gandu
- Department of Cell Biology and Neuroscience, Cell and Development Biology Graduate Program, The State University of New Jersey, Piscataway, NJ, 08854, USA
| | - Harbinder Singh
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, PB, 143005, India.
| | - Sahil Sharma
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, PB, 143005, India.
- Program in Chemical Biology, Sloan Kettering Institute, New York, NY, 10065, USA.
| | - Preet Mohinder S Bedi
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, PB, 143005, India.
| |
Collapse
|
8
|
Shuto S. [Medicinal Chemical Studies Based on the Theoretical Design of Bioactive Compounds]. YAKUGAKU ZASSHI 2020; 140:329-344. [PMID: 32115550 DOI: 10.1248/yakushi.19-00208] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
I have engaged in medicinal chemical studies based on the theoretical design of bioactive compounds. First, I present a three-dimensional structural diversity-oriented conformational restriction strategy for developing bioactive compounds based on the characteristic steric and stereoelectronic features of cyclopropane. Using this strategy, various biologically active small molecule compounds, such as receptor agonists/antagonists and enzyme inhibitors, were effectively developed. The strategy was also applied to develop versatile peptidomimetics and membrane-permeable cyclic peptides. Next, studies on Ca2+-mobilizing second messengers, cyclic ADP-ribose (cADPR) and myo-inositol trisphosphates (IP3), are described. In these studies, stable equivalents of cADPR were developed, since biological studies of cADPR have been limited due to its instability. Various potent IP3 receptor ligands, which were designed using the d-glucose structure as a bioisostere of the myo-inositol moiety of IP3, have been identified. Organic chemistry studies have also been extensively performed, because excellent organic chemistry is essential for promoting high-level medicinal chemical studies. For examples, new methods for the synthesis of chiral cyclopropanes, new radical reactions with silicon tethers, and kinetic anomeric effect-dependent stereoselective glycosidations have been developed.
Collapse
Affiliation(s)
- Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University
| |
Collapse
|
9
|
Watanabe M, Kobayashi T, Ito Y, Yamada S, Shuto S. Conformational Restriction of Histamine with a Rigid Bicyclo[3.1.0]hexane Scaffold Provided Selective H 3 Receptor Ligands. Molecules 2020; 25:molecules25163562. [PMID: 32764432 PMCID: PMC7463632 DOI: 10.3390/molecules25163562] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Revised: 07/30/2020] [Accepted: 08/04/2020] [Indexed: 01/12/2023] Open
Abstract
We designed and synthesized conformationally rigid histamine analogues with a bicyclo[3.1.0]hexane scaffold. All the compounds were selectively bound to the H3 receptor subtype over the H4 receptor subtype. Notably, compound 7 showed potent binding affinity and over 100-fold selectivity for the H3 receptors (Ki = 5.6 nM for H3 and 602 nM for H4). These results suggest that the conformationally rigid bicyclo[3.1.0]hexane structure can be a useful scaffold for developing potent ligands selective for the target biomolecules.
Collapse
Affiliation(s)
- Mizuki Watanabe
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060–0812, Japan;
- Correspondence: (M.W.); (S.S.)
| | - Takaaki Kobayashi
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060–0812, Japan;
| | - Yoshihiko Ito
- Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka 422–8526, Japan; (Y.I.); (S.Y.)
| | - Shizuo Yamada
- Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka 422–8526, Japan; (Y.I.); (S.Y.)
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060–0812, Japan;
- Center for Research and Education on Drug Discovery, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060–0812, Japan
- Correspondence: (M.W.); (S.S.)
| |
Collapse
|
10
|
Konishi S, Mitani Y, Mori N, Takikawa H, Watanabe H. First enantioselective synthesis of exiguamide, a nitrogen-containing spirocyclic sesquiterpene isolated from the marine sponge Geodia exigua. Tetrahedron 2019. [DOI: 10.1016/j.tet.2018.12.046] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Minami T, Fukuda K, Hoshiya N, Fukuda H, Watanabe M, Shuto S. Synthesis of Enantiomerically Pure 1,2,3-Trisubstituted Cyclopropane Nucleosides Using Pd-Catalyzed Substitution via Directing Group-Mediated C(sp3)–H Activation as a Key Step. Org Lett 2019; 21:656-659. [DOI: 10.1021/acs.orglett.8b03785] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
12
|
Suemasa A, Watanabe M, Kobayashi T, Suzuki H, Fukuda H, Minami M, Shuto S. Design and synthesis of cyclopropane-based conformationally restricted GABA analogues as selective inhibitors for betaine/GABA transporter 1. Bioorg Med Chem Lett 2018; 28:3395-3399. [DOI: 10.1016/j.bmcl.2018.08.031] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2018] [Revised: 08/25/2018] [Accepted: 08/25/2018] [Indexed: 12/26/2022]
|
13
|
Watanabe M, Kobayashi T, Ito Y, Fukuda H, Yamada S, Arisawa M, Shuto S. Design and synthesis of histamine H 3/H 4 receptor ligands with a cyclopropane scaffold. Bioorg Med Chem Lett 2018; 28:3630-3633. [PMID: 30385161 DOI: 10.1016/j.bmcl.2018.10.041] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Revised: 10/19/2018] [Accepted: 10/24/2018] [Indexed: 12/27/2022]
Abstract
We previously designed and synthesized a series of histamine analogues with an imidazolylcyclopropane scaffold and identified potent non-selective antagonists for histamine H3 and H4 receptor subtypes. In this study, to develop H4 selective ligands, we newly designed and synthesized cyclopropane-based derivatives having an indole, benzimidazole, or piperazine structure, which are components of representative H4 selective antagonists such as JNJ7777120 and JNJ10191584. Among the synthesized derivatives, imidazolylcyclopropanes 12 and 13 conjugated with a benzimidazole showed binding affinity to the H3 and H4 receptors comparable to that of a well-known non-selective H3/H4 antagonist, thioperamide. These results suggest that the binding modes of the cyclopropane-based H3/H4 ligands in the H4 receptor can be different from those of the indole/benzimidazole-piperazine derivatives.
Collapse
Affiliation(s)
- Mizuki Watanabe
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | - Takaaki Kobayashi
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Yoshihiko Ito
- Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka 422-8526, Japan
| | - Hayato Fukuda
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Shizuo Yamada
- Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka 422-8526, Japan
| | - Mitsuhiro Arisawa
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| |
Collapse
|
14
|
Zheng L, Zhou B, Jin H, Li T, Liu Y. Radical-Triggered Tandem Cyclization of 1,6-Enynes with H2O: A Way to Access Strained 1H-Cyclopropa[b]naph thalene-2,7-diones. Org Lett 2018; 20:7053-7056. [DOI: 10.1021/acs.orglett.8b03007] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Limeng Zheng
- State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, Zhejiang University of Technology, Hangzhou, 310014, P. R. China
| | - Bingwei Zhou
- State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, Zhejiang University of Technology, Hangzhou, 310014, P. R. China
| | - Hongwei Jin
- State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, Zhejiang University of Technology, Hangzhou, 310014, P. R. China
| | - Ting Li
- College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nangyang, Henan 473061, P. R. China
| | - Yunkui Liu
- State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, Zhejiang University of Technology, Hangzhou, 310014, P. R. China
| |
Collapse
|
15
|
Konrádová D, Bon DJYD, Pospíšil J. 1-(Phenylsulfonyl)-3-oxabicyclo[3.1.0]hexan-2-one as a Building Block in Organic Synthesis. J Org Chem 2018; 83:12229-12238. [PMID: 30188126 DOI: 10.1021/acs.joc.8b01625] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The transformation of the readily available phenylsulfonyl lactone building block to structurally diverse molecular scaffolds is described. Depicted structures are accessed in one to three steps, and their overall yields are high. The rigidity of the starting building block greatly directs the stereoselectivity of the transformations, and newly generated stereogenic centers including the quaternary carbon centers are formed with high stereoselectivity generally superior to dr > 95:1.
Collapse
Affiliation(s)
- Daniela Konrádová
- Laboratory of Growth Regulators , Palacky University & Institute of Experimental Botany AS CR , Šlechtitelů 27 , CZ-783 71 Olomouc , Czech Republic
| | - David Jean-Yves Denis Bon
- Department of Organic Chemistry, Faculty of Science , Palacky University , tř. 17. listopadu 1192/12 , CZ-771 46 Olomouc , Czech republic
| | - Jiří Pospíšil
- Laboratory of Growth Regulators , Palacky University & Institute of Experimental Botany AS CR , Šlechtitelů 27 , CZ-783 71 Olomouc , Czech Republic.,Department of Organic Chemistry, Faculty of Science , Palacky University , tř. 17. listopadu 1192/12 , CZ-771 46 Olomouc , Czech republic
| |
Collapse
|
16
|
Kanada R, Tanabe M, Muromoto R, Sato Y, Kuwahara T, Fukuda H, Arisawa M, Matsuda T, Watanabe M, Shuto S. Synthesis of Chiral cis-Cyclopropane Bearing Indole and Chromone as Potential TNFα Inhibitors. J Org Chem 2018; 83:7672-7682. [PMID: 30004223 DOI: 10.1021/acs.joc.8b00466] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Conformationally restricted analogues of SPD-304, the first small-molecule TNFα inhibitor, in which two heteroaryl groups, indole and chromone, are connected by chiral methyl- or ethyl- cis-cyclopropane, were designed. Synthesis of these molecules was achieved via Suzuki-Miyaura or Stille coupling reactions with chiral bromomethylenecyclopropane or iodovinyl- cis-cyclopropane as the substrate, both of which were prepared from chiral methylenecyclopropane as a common intermediate, constructing the heteroaryl-methyl or -ethyl- cis-cyclopropane structures as key steps. This study presents an efficient synthesis of a series of chiral cis-cyclopropane conjugates with two heteroaryl groups.
Collapse
Affiliation(s)
- Ryutaro Kanada
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Makoto Tanabe
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Ryuta Muromoto
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Yukina Sato
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Tomoki Kuwahara
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Hayato Fukuda
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Mitsuhiro Arisawa
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Tadashi Matsuda
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Mizuki Watanabe
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6, Kita-ku , Sapporo 060-0812 , Japan
| |
Collapse
|
17
|
Urban M, Franc M, Hofmanová M, Císařová I, Veselý J. The enantioselective addition of 1-fluoro-1-nitro(phenylsulfonyl)methane to isatin-derived ketimines. Org Biomol Chem 2018; 15:9071-9076. [PMID: 29083001 DOI: 10.1039/c7ob02408h] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
An asymmetric organocatalytic addition of fluorinated phenylsulfonylnitromethane to isatin-derived ketimines was developed. The reaction was efficiently catalyzed by a chiral tertiary amine, cinchonine. This methodology provides a new type of optically active compound with two adjacent quaternary carbon stereocenters in good yield (up to 96%), with moderate diastereoselectivity (up to 5.7 : 1 dr) and excellent enantioselectivity (up to 98/96% ee).
Collapse
Affiliation(s)
- M Urban
- Department of Organic Chemistry, Charles University, Hlavova 8, 12843 Prague, Czech Republic.
| | - M Franc
- Department of Organic Chemistry, Charles University, Hlavova 8, 12843 Prague, Czech Republic.
| | - M Hofmanová
- Department of Organic Chemistry, Charles University, Hlavova 8, 12843 Prague, Czech Republic.
| | - I Císařová
- Department of Inorganic Chemistry, Charles University, Hlavova 8, 12843 Prague, Czech Republic
| | - J Veselý
- Department of Organic Chemistry, Charles University, Hlavova 8, 12843 Prague, Czech Republic.
| |
Collapse
|
18
|
Hoshiya N, Kondo M, Fukuda H, Arisawa M, Uenishi J, Shuto S. Entry to Chiral 1,1,2,3-Tetrasubstituted Arylcyclopropanes by Pd(II)-Catalyzed Arylation via Directing Group-Mediated C(sp3)-H Activation. J Org Chem 2017; 82:2535-2544. [DOI: 10.1021/acs.joc.6b02935] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Naoyuki Hoshiya
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
- Department
of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Shichonocho
1, Misasagi, Yamashina, Kyoto 607-8412, Japan
| | - Moemi Kondo
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
| | - Hayato Fukuda
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
| | - Mitsuhiro Arisawa
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
- Graduate
School of Pharmaceutical Sciences, Osaka University, Yamada-oka
1-6, Suita, Osaka 565-0862, Japan
| | - Jun’ichi Uenishi
- Department
of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Shichonocho
1, Misasagi, Yamashina, Kyoto 607-8412, Japan
| | - Satoshi Shuto
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
- Center
for Research and Education on Drug Discovery, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
| |
Collapse
|
19
|
Kumar V, Moritz AE, Keck TM, Bonifazi A, Ellenberger MP, Sibley CD, Free RB, Shi L, Lane JR, Sibley DR, Newman AH. Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D 3 Receptor (D 3R). J Med Chem 2017; 60:1478-1494. [PMID: 28186762 DOI: 10.1021/acs.jmedchem.6b01688] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The development of bitopic ligands directed toward D2-like receptors has proven to be of particular interest to improve the selectivity and/or affinity of these ligands and as an approach to modulate and bias their efficacies. The structural similarities between dopamine D3 receptor (D3R)-selective molecules that display bitopic or allosteric pharmacology and those that are simply competitive antagonists are subtle and intriguing. Herein we synthesized a series of molecules in which the primary and secondary pharmacophores were derived from the D3R-selective antagonists SB269,652 (1) and SB277011A (2) whose structural similarity and pharmacological disparity provided the perfect templates for SAR investigation. Incorporating a trans-cyclopropylmethyl linker between pharmacophores and manipulating linker length resulted in the identification of two bivalent noncompetitive D3R-selective antagonists, 18a and 25a, which further delineates SAR associated with allosterism at D3R and provides leads toward novel drug development.
Collapse
Affiliation(s)
- Vivek Kumar
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health , 333 Cassell Drive, Baltimore, Maryland 21224, United States
| | - Amy E Moritz
- Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health , 35 Convent Drive, MSC-3723, Bethesda, Maryland 20892-3723, United States
| | - Thomas M Keck
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health , 333 Cassell Drive, Baltimore, Maryland 21224, United States
| | - Alessandro Bonifazi
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health , 333 Cassell Drive, Baltimore, Maryland 21224, United States
| | - Michael P Ellenberger
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health , 333 Cassell Drive, Baltimore, Maryland 21224, United States
| | - Christopher D Sibley
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health , 333 Cassell Drive, Baltimore, Maryland 21224, United States
| | - R Benjamin Free
- Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health , 35 Convent Drive, MSC-3723, Bethesda, Maryland 20892-3723, United States
| | - Lei Shi
- Computational Chemistry and Molecular Biophysics Unit, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health , 333 Cassell Drive, Baltimore, Maryland 21224, United States
| | - J Robert Lane
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University , 399 Royal Parade, Parkville, Victoria 3052, Australia
| | - David R Sibley
- Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health , 35 Convent Drive, MSC-3723, Bethesda, Maryland 20892-3723, United States
| | - Amy Hauck Newman
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health , 333 Cassell Drive, Baltimore, Maryland 21224, United States
| |
Collapse
|
20
|
Matsui K, Kido Y, Watari R, Kashima Y, Yoshida Y, Shuto S. Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides. Chemistry 2016; 23:3034-3041. [PMID: 27878880 DOI: 10.1002/chem.201604946] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2016] [Indexed: 12/21/2022]
Abstract
The conformation of cyclic peptides is closely related to their physicochemical and biological properties, but their rational design to obtain a conformation with the desired properties is difficult. Herein, we present a new strategy by using conformationally restricted cyclopropane tethers (CPTs) to control the conformation and improve the cell permeability of cyclic peptides regardless of the amino acid sequence. Newly designed cis- or trans-CPTs with three-dimensional structural diversity were introduced into a model cyclic peptide, and the relationship between the conformation of the cyclic peptides and their cell permeability was analyzed. Peptides containing a CPT exhibited conformational diversity due to the characteristic steric feature of cyclopropane, among which peptides containing a CPT, cis-NfCf had remarkably higher cell permeability than peptides containing other CPTs-even superior to that of cyclosporine A, a known permeable cyclic peptide.
Collapse
Affiliation(s)
- Kouhei Matsui
- Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan
| | - Yasuto Kido
- Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan
| | - Ryosuke Watari
- Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan
| | - Yousuke Kashima
- Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan
| | - Yutaka Yoshida
- Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan
| |
Collapse
|
21
|
Synthesis of novel non-natural conformationally restricted cyclopropane amino acids of spirane series. Russ Chem Bull 2016. [DOI: 10.1007/s11172-015-1135-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
22
|
Zhu Y, Gong Y. Highly regioselective tandem formal substitution and decarboxylation of 2-acyl-1-chlorocyclopropanecarboxylates with sodium sulfinates. Tetrahedron 2016. [DOI: 10.1016/j.tet.2016.04.062] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Hoshiya N, Takenaka K, Shuto S, Uenishi J. Pd(II)-Catalyzed Alkylation of Tertiary Carbon via Directing-Group-Mediated C(sp3)–H Activation: Synthesis of Chiral 1,1,2-Trialkyl Substituted Cyclopropanes. Org Lett 2015; 18:48-51. [DOI: 10.1021/acs.orglett.5b03229] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Naoyuki Hoshiya
- Department
of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto 607-8412, Japan
| | - Kei Takenaka
- Department
of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto 607-8412, Japan
| | - Satoshi Shuto
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo, 060-0812, Japan
- Center
for Research and Education on Drug Discovery, Hokkaido University, Kita 12, Nishi
6, Kita-ku, Sapporo, 060-0812, Japan
| | - Jun’ichi Uenishi
- Department
of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto 607-8412, Japan
| |
Collapse
|
24
|
Nicolaou KC, Vourloumis D, Totokotsopoulos S, Papakyriakou A, Karsunky H, Fernando H, Gavrilyuk J, Webb D, Stepan AF. Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural Motifs. ChemMedChem 2015; 11:31-7. [PMID: 26585829 DOI: 10.1002/cmdc.201500510] [Citation(s) in RCA: 79] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2015] [Indexed: 11/10/2022]
Abstract
A convenient synthesis of imatinib, a potent inhibitor of ABL1 kinase and widely prescribed drug for the treatment of a variety of leukemias, was devised and applied to the construction of a series of novel imatinib analogues featuring a number of non-aromatic structural motifs in place of the parent molecule's phenyl moiety. These analogues were subsequently evaluated for their biopharmaceutical properties (e.g., ABL1 kinase inhibitory activity, cytotoxicity). The bicyclo[1.1.1]pentane- and cubane-containing analogues were found to possess higher themodynamic solubility, whereas cubane- and cyclohexyl-containing analogues exhibited the highest inhibitory activity against ABL1 kinase and the most potent cytotoxicity values against cancer cell lines K562 and SUP-B15. Molecular modeling was employed to rationalize the weak activity of the compounds against ABL1 kinase, and it is likely that the observed cytotoxicity of these agents arises through off-target effects.
Collapse
Affiliation(s)
- Kyriacos C Nicolaou
- Department of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA.
| | - Dionisios Vourloumis
- Department of Chemistry, Rice University, 6100 Main Street, Houston, TX, 77005, USA. , .,Laboratory of Chemical Biology of Natural Products & Designed Molecules, National Centre of Scientific Research (NCSR) "Demokritos", Agia Paraskevi, Athens, 15310, Greece. ,
| | | | - Athanasios Papakyriakou
- Laboratory of Chemical Biology of Natural Products & Designed Molecules, National Centre of Scientific Research (NCSR) "Demokritos", Agia Paraskevi, Athens, 15310, Greece
| | - Holger Karsunky
- Stemcentrx, Inc., 450 East Jamie Court, San Francisco, CA, 94080, USA
| | - Hanan Fernando
- Stemcentrx, Inc., 450 East Jamie Court, San Francisco, CA, 94080, USA
| | - Julia Gavrilyuk
- Stemcentrx, Inc., 450 East Jamie Court, San Francisco, CA, 94080, USA
| | - Damien Webb
- Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, MA, 02139, USA
| | - Antonia F Stepan
- Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, MA, 02139, USA.
| |
Collapse
|
25
|
Yotsuji K, Hoshiya N, Kobayashi T, Fukuda H, Abe H, Arisawa M, Shuto S. Nickel-Catalyzed Suzuki-Miyaura Coupling of a Tertiary Iodocyclopropane with Wide Boronic Acid Substrate Scope: Coupling Reaction Outcome Depends on Radical Species Stability. Adv Synth Catal 2015. [DOI: 10.1002/adsc.201401000] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
26
|
Arichi N, Hata K, Takemoto Y, Yamada KI, Yamaoka Y, Takasu K. Synthesis of steroidal derivatives bearing a small ring using a catalytic [2+2] cycloaddition and a ring-contraction rearrangement. Tetrahedron 2015. [DOI: 10.1016/j.tet.2014.11.065] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
27
|
Kobayashi T, Suemasa A, Igawa A, Ide S, Fukuda H, Abe H, Arisawa M, Minami M, Shuto S. Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor. ACS Med Chem Lett 2014; 5:889-93. [PMID: 25147609 DOI: 10.1021/ml500134k] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2014] [Accepted: 06/16/2014] [Indexed: 11/29/2022] Open
Abstract
On the basis of the three-dimensional diversity-oriented conformational restriction strategy using key chiral cyclopropane units, we previously identified 3 ((2S,3R)-4-amino-3,4-methanobutyric acid) with a chiral trans-cyclopropane structure as a γ-aminobutyric acid (GABA) transporter inhibitor selective for GABA transporter (GAT) subtypes GAT-3 and BGT-1 (betaine/GABA transporter-1). Further conformational restriction of 3 with the rigid bicyclo[3.1.0]hexane backbone led to the successful development of the first highly potent and selective BGT-1 inhibitor 4 (IC50 = 0.59 μM). The bioactive conformation of 3 for BGT-1 was also identified.
Collapse
Affiliation(s)
- Takaaki Kobayashi
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Akihiro Suemasa
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Arisa Igawa
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Soichiro Ide
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Hayato Fukuda
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Hiroshi Abe
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Mitsuhiro Arisawa
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Masabumi Minami
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12,
Nishi-6, Kita-ku, Sapporo 060-0812, Japan
- Center for Research
and Education on Drug Discovery, Hokkaido University, Kita-ku, Sapporo 060-0812, Japan
| |
Collapse
|
28
|
Arisawa M, Sato T, Hoshiya N, Al-Amin M, Kogami Y, Shuto S. Ligand-free Suzuki-Miyaura coupling with sulfur-modified gold-supported palladium in the synthesis of a conformationally-restricted cyclopropane compound library with three-dimensional diversity. ACS COMBINATORIAL SCIENCE 2014; 16:215-20. [PMID: 24697302 DOI: 10.1021/co4001138] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
A conformationally restricted privileged structure library with stereochemical diversity for a "fragment growth" methodology comprising 90 compounds was designed and systematically and efficiently synthesized using sulfur-modified Au-supported Pd (SAPd)-catalyzed ligand-free Suzuki-Miyaura coupling of vinyl iodide promoted by microwave and subsequent amidation in liquid-phase combinatorial chemistry as key reactions. Evaluation of the compounds with a 20-kinase panel indicated the usefulness of this "fragment growth" methodology for finding hit library compounds for fragment-based drug discovery.
Collapse
Affiliation(s)
- Mitsuhiro Arisawa
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
- ACT-C, Japan Science and Technology Agency (JST), Sapporo 060-0812, Japan
- Graduate
School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka 565-0871, Japan
| | - Takatoshi Sato
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
| | - Naoyuki Hoshiya
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
- Furuya Metal Company Limited, Tokyo 170-0005, Japan
| | - Mohammad Al-Amin
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
| | - Yuji Kogami
- D.D.P. Corporation, 1097-3, Kashiya, Kannami-cho, Shizuoka 419-0112, Japan
| | - Satoshi Shuto
- Faculty
of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
- Center
for Research and Education on Drug Discovery, Hokkaido University, Kita 12, Nishi 6, Kita-ku,
Sapporo 060-0812, Japan
| |
Collapse
|
29
|
|
30
|
Hoshiya N, Kobayashi T, Arisawa M, Shuto S. Palladium-Catalyzed Arylation of Cyclopropanes via Directing Group-Mediated C(sp3)–H Bond Activation To Construct Quaternary Carbon Centers: Synthesis of cis- and trans-1,1,2-Trisubstituted Chiral Cyclopropanes. Org Lett 2013; 15:6202-5. [DOI: 10.1021/ol4030452] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Naoyuki Hoshiya
- Faculty of Pharmaceutical Sciences and Center for Research and Education on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Takaaki Kobayashi
- Faculty of Pharmaceutical Sciences and Center for Research and Education on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Mitsuhiro Arisawa
- Faculty of Pharmaceutical Sciences and Center for Research and Education on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences and Center for Research and Education on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| |
Collapse
|
31
|
Tanabe M, Watanabe M, Hoshiya N, Mizuno A, Fukuda H, Arisawa M, Shuto S. Preparation of Chiral Bromomethylenecyclopropane and Its Use in Suzuki–Miyaura Coupling: Synthesis of the Arylmethyl-(Z)-cyclopropane Structure Core. J Org Chem 2013; 78:11714-20. [DOI: 10.1021/jo401675z] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Makoto Tanabe
- Faculty of Pharmaceutical Sciences and ‡Center for Research
and Education
on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Mizuki Watanabe
- Faculty of Pharmaceutical Sciences and ‡Center for Research
and Education
on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Naoyuki Hoshiya
- Faculty of Pharmaceutical Sciences and ‡Center for Research
and Education
on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Akira Mizuno
- Faculty of Pharmaceutical Sciences and ‡Center for Research
and Education
on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Hayato Fukuda
- Faculty of Pharmaceutical Sciences and ‡Center for Research
and Education
on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Mitsuhiro Arisawa
- Faculty of Pharmaceutical Sciences and ‡Center for Research
and Education
on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences and ‡Center for Research
and Education
on Drug Development, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| |
Collapse
|
32
|
Ishizuka Y, Fujimori H, Noguchi T, Kawasaki M, Kishida M, Nagai T, Imai N, Kirihara M. Asymmetric Syntheses of Pharmaceuticals Containing a Cyclopropane Moiety Using Catalytic Asymmetric Simmons–Smith Reactions of Allylalcohols: Syntheses of Optically Active Tranylcypromine and Milnacipran. CHEM LETT 2013. [DOI: 10.1246/cl.130498] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Yuki Ishizuka
- Department of Materials and Life Science, Shizuoka Institute of Science and Technology
| | - Hirohisa Fujimori
- Department of Materials and Life Science, Shizuoka Institute of Science and Technology
| | - Takuya Noguchi
- Department of Materials and Life Science, Shizuoka Institute of Science and Technology
- Faculty of Parmacy, Chiba Institute of Science
| | | | - Mari Kishida
- Department of Materials and Life Science, Shizuoka Institute of Science and Technology
| | | | | | - Masayuki Kirihara
- Department of Materials and Life Science, Shizuoka Institute of Science and Technology
| |
Collapse
|
33
|
Yonezawa S, Fujiwara K, Yamamoto T, Hattori K, Yamakawa H, Muto C, Hosono M, Tanaka Y, Nakano T, Takemoto H, Arisawa M, Shuto S. Conformational restriction approach to β-secretase (BACE1) inhibitors III: effective investigation of the binding mode by combinational use of X-ray analysis, isothermal titration calorimetry and theoretical calculations. Bioorg Med Chem 2013; 21:6506-22. [PMID: 24051074 DOI: 10.1016/j.bmc.2013.08.036] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2013] [Revised: 08/18/2013] [Accepted: 08/20/2013] [Indexed: 12/22/2022]
Abstract
For further investigation of BACE1 inhibitors using conformational restriction with sp(3) hybridized carbon, we applied this approach to 6-substituted aminopyrimidone derivatives 3 to improve the inhibitory activity by reducing the entropic energy loss upon binding to BACE1. Among eight stereoisomers synthesized, [trans-(1'R,2'R),6S] isomer 6 exhibited the best BACE1 inhibitory activity, which was statistically superior to that of the corresponding ethylene linker compound (R)-3. Combinational examinations of the binding mode of 6 were performed, which included isothermal titration calorimetry (ITC), X-ray crystallographic structure analysis and theoretical calculations, to clarify the effect of our conformational restriction approach. From the ITC measurement, the binding entropy of 6 was found to be ∼0.5kcal larger than that of (R)-3, which is considered to be affected by conformational restriction with a cyclopropane ring.
Collapse
Affiliation(s)
- Shuji Yonezawa
- Shionogi Innovation Center for Drug Discovery, Shionogi & Co., Ltd, Kita-21 Nishi-11 Kita-ku, Sapporo 001-0021, Japan; Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Kawamura S, Unno Y, Tanaka M, Sasaki T, Yamano A, Hirokawa T, Kameda T, Asai A, Arisawa M, Shuto S. Investigation of the Noncovalent Binding Mode of Covalent Proteasome Inhibitors around the Transition State by Combined Use of Cyclopropylic Strain-Based Conformational Restriction and Computational Modeling. J Med Chem 2013; 56:5829-42. [DOI: 10.1021/jm400542h] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
| | - Yuka Unno
- Graduate School of Pharmaceutical Sciences, University of Shizuoka, Yada, Shizuoka 422-8526, Japan
| | - Motohiro Tanaka
- School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku,
Nagoya 464-8650, Japan
| | - Takuma Sasaki
- School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku,
Nagoya 464-8650, Japan
| | - Akihito Yamano
- Rigaku Corporation, X-ray Institute, 3-9-12
Matsubara-cho, Akishima, Tokyo 196-8666, Japan
| | - Takatsugu Hirokawa
- Computational Biology Research Center (CBRC), National Institute of Advanced Industrial Science and Technology (AIST), 2-4-7 Aomi, Koutou-ku, Tokyo 135-0064, Japan
| | - Tomoshi Kameda
- Computational Biology Research Center (CBRC), National Institute of Advanced Industrial Science and Technology (AIST), 2-4-7 Aomi, Koutou-ku, Tokyo 135-0064, Japan
| | - Akira Asai
- Graduate School of Pharmaceutical Sciences, University of Shizuoka, Yada, Shizuoka 422-8526, Japan
| | | | | |
Collapse
|
35
|
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports. Bioorg Med Chem 2013; 21:4938-50. [PMID: 23886812 DOI: 10.1016/j.bmc.2013.06.063] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2013] [Revised: 06/26/2013] [Accepted: 06/26/2013] [Indexed: 12/22/2022]
Abstract
A series of cyclopropane-based conformationally restricted γ-aminobutyric acid (GABA) analogs with stereochemical diversity, that is, the trans- and cis-2,3-methano analogs Ia and Ib and their enantiomers ent-Ia and ent-Ib, and also the trans- and cis-3,4-methano analogs IIa and IIb and their enantiomers ent-IIa and ent-Iib, were synthesized from the chiral cyclopropane units Type-a and Type-b that we developed. These analogs were systematically evaluated with four GABA transporter (GAT) subtypes. The trans-3,4-methano analog IIa had inhibitory effects on GAT3 (IC50=23.9μM) and betaine-GABA transporter1 (5.48μM), indicating its potential as an effective lead compound for the development of potent GAT inhibitors due to its hydrophilic and low molecular weight properties and excellent ligand efficiency.
Collapse
|
36
|
Kawamura S, Unno Y, List A, Mizuno A, Tanaka M, Sasaki T, Arisawa M, Asai A, Groll M, Shuto S. Potent Proteasome Inhibitors Derived from the Unnatural cis-Cyclopropane Isomer of Belactosin A: Synthesis, Biological Activity, and Mode of Action. J Med Chem 2013; 56:3689-700. [DOI: 10.1021/jm4002296] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Affiliation(s)
- Shuhei Kawamura
- Faculty of
Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo
060-0812, Japan
| | - Yuka Unno
- Graduate
School of Pharmaceutical
Sciences, University of Shizuoka, Yada,
Shizuoka 422-8526, Japan
| | - Anja List
- Center for Integrated Protein
Science at the Department of Chemistry, Chair of Biochemistry, Technische Universität München, Lichtenbergstrasse
4, 85747 Garching, Germany
| | - Akirai Mizuno
- Faculty of
Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo
060-0812, Japan
| | - Motohiro Tanaka
- School of Pharmacy, Aichi Gakuin
University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan
| | - Takuma Sasaki
- School of Pharmacy, Aichi Gakuin
University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan
| | - Mitsuhiro Arisawa
- Faculty of
Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo
060-0812, Japan
| | - Akira Asai
- Graduate
School of Pharmaceutical
Sciences, University of Shizuoka, Yada,
Shizuoka 422-8526, Japan
| | - Michael Groll
- Center for Integrated Protein
Science at the Department of Chemistry, Chair of Biochemistry, Technische Universität München, Lichtenbergstrasse
4, 85747 Garching, Germany
| | - Satoshi Shuto
- Faculty of
Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo
060-0812, Japan
| |
Collapse
|
37
|
Singh GS, Mollet K, D’hooghe M, De Kimpe N. Epihalohydrins in Organic Synthesis. Chem Rev 2012; 113:1441-98. [DOI: 10.1021/cr3003455] [Citation(s) in RCA: 60] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Girija S. Singh
- Chemistry Department, Faculty
of Science, University of Botswana, Private
Bag 0022, Gaborone, Botswana
| | - Karen Mollet
- Department of Sustainable Organic
Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000 Ghent,
Belgium
| | - Matthias D’hooghe
- Department of Sustainable Organic
Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000 Ghent,
Belgium
| | - Norbert De Kimpe
- Department of Sustainable Organic
Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000 Ghent,
Belgium
| |
Collapse
|
38
|
Yonezawa S, Yamamoto T, Yamakawa H, Muto C, Hosono M, Hattori K, Higashino K, Yutsudo T, Iwamoto H, Kondo Y, Sakagami M, Togame H, Tanaka Y, Nakano T, Takemoto H, Arisawa M, Shuto S. Conformational Restriction Approach to β-Secretase (BACE1) Inhibitors: Effect of a Cyclopropane Ring To Induce an Alternative Binding Mode. J Med Chem 2012; 55:8838-58. [PMID: 22998419 DOI: 10.1021/jm3011405] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Shuji Yonezawa
- Shionogi Innovation Center for Drug Discovery, Shionogi & Co., Ltd., Kita-21 Nishi-11 Kita-ku, Sapporo 001-0021, Japan
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo
060-0812, Japan
| | - Takahiko Yamamoto
- Pharmaceutical Research Division, Medicinal Research Laboratories, and Innovative Drug Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Hidekuni Yamakawa
- Pharmaceutical Research Division, Medicinal Research Laboratories, and Innovative Drug Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Chie Muto
- Pharmaceutical Research Division, Medicinal Research Laboratories, and Innovative Drug Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Motoko Hosono
- Pharmaceutical Research Division, Medicinal Research Laboratories, and Innovative Drug Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Kazunari Hattori
- Pharmaceutical Research Division, Medicinal Research Laboratories, and Innovative Drug Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Kenichi Higashino
- Shionogi Innovation Center for Drug Discovery, Shionogi & Co., Ltd., Kita-21 Nishi-11 Kita-ku, Sapporo 001-0021, Japan
| | - Takashi Yutsudo
- Pharmaceutical Research Division, Medicinal Research Laboratories, and Innovative Drug Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Hideo Iwamoto
- Shionogi Techno Advance Research
Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Yutaka Kondo
- Shionogi Techno Advance Research
Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Masahiro Sakagami
- Pharmaceutical Research Division, Medicinal Research Laboratories, and Innovative Drug Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Hiroko Togame
- Quality, Safety and Regulatory Affairs Management Division, Shionogi & Co., Ltd., 1-8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045, Japan
| | - Yoshikazu Tanaka
- Shionogi Innovation Center for Drug Discovery, Shionogi & Co., Ltd., Kita-21 Nishi-11 Kita-ku, Sapporo 001-0021, Japan
| | - Toru Nakano
- Shionogi Innovation Center for Drug Discovery, Shionogi & Co., Ltd., Kita-21 Nishi-11 Kita-ku, Sapporo 001-0021, Japan
| | - Hiroshi Takemoto
- Pharmaceutical Research Division, Medicinal Research Laboratories, and Innovative Drug Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan
| | - Mitsuhiro Arisawa
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo
060-0812, Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo
060-0812, Japan
| |
Collapse
|
39
|
Watanabe M, Kobayashi T, Hirokawa T, Yoshida A, Ito Y, Yamada S, Orimoto N, Yamasaki Y, Arisawa M, Shuto S. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: Histamine H3and/or H4receptor ligands with the 2,3-methanobutane backbone. Org Biomol Chem 2012; 10:736-45. [DOI: 10.1039/c1ob06496g] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
40
|
Kato H, Ishigame T, Oshima N, Hoshiya N, Shimawaki K, Arisawa M, Shuto S. One-Pot Ring-Closing Metathesis (RCM)/Oxidation by an Assisted Tandem Ruthenium Catalysis for the Synthesis of 2-Quinolones. Adv Synth Catal 2011. [DOI: 10.1002/adsc.201100303] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
41
|
Watanabe M, Yamaguchi K, Tang W, Yoshida K, Silverman RB, Arisawa M, Shuto S. Synthesis of a series of 3,4-methanoarginines as side-chain conformationally restricted analogues of arginine. Bioorg Med Chem 2011; 19:5984-8. [DOI: 10.1016/j.bmc.2011.08.049] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2011] [Revised: 08/20/2011] [Accepted: 08/22/2011] [Indexed: 12/21/2022]
|
42
|
Affiliation(s)
- Charles M. Marson
- Department of Chemistry, University College London, Christopher Ingold Laboratories, 20 Gordon Street, London WC1H OAJ, United Kingdom
| |
Collapse
|
43
|
Kobayashi T, Arisawa M, Shuto S. Alkene isomerization/enamide-ene and diene metathesis for the construction of indoles, quinolines, benzofurans and chromenes with a chiral cyclopropane substituent. Org Biomol Chem 2011; 9:1219-24. [DOI: 10.1039/c0ob00597e] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
44
|
Bray CD, de Faveri G. Stereocontrolled Synthesis of trans-Cyclopropyl Sulfones from Terminal Epoxides. J Org Chem 2010; 75:4652-5. [DOI: 10.1021/jo100844g] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Christopher D. Bray
- Queen Mary University of London, School of Biological and Chemical Sciences, Mile End Road, London E1 4NS, U.K
| | - Giorgio de Faveri
- Queen Mary University of London, School of Biological and Chemical Sciences, Mile End Road, London E1 4NS, U.K
| |
Collapse
|
45
|
The conversion of alkynes into substituted cyclopropanes effected by CH2I2-R3Al (R = Me, Et, i-Bu). J Organomet Chem 2010. [DOI: 10.1016/j.jorganchem.2010.04.002] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
46
|
Watanabe M, Hirokawa T, Kobayashi T, Yoshida A, Ito Y, Yamada S, Orimoto N, Yamasaki Y, Arisawa M, Shuto S. Investigation of the Bioactive Conformation of Histamine H3 Receptor Antagonists by the Cyclopropylic Strain-Based Conformational Restriction Strategy. J Med Chem 2010; 53:3585-93. [DOI: 10.1021/jm901848b] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Mizuki Watanabe
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Takatsugu Hirokawa
- Computational Biology Research Center, National Institute of Advanced Industrial Science and Technology, Aomi, Koutou-ku, Tokyo 135-0064, Japan
| | - Takaaki Kobayashi
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Akira Yoshida
- Department of Pharmacokinetics and Pharmacodynammics and Global Center of Excellence (COE), School of Pharmaceutical Sciences, University of Shizuoka, Yada, Shizuoka 422-8526, Japan
| | - Yoshihiko Ito
- Department of Pharmacokinetics and Pharmacodynammics and Global Center of Excellence (COE), School of Pharmaceutical Sciences, University of Shizuoka, Yada, Shizuoka 422-8526, Japan
| | - Shizuo Yamada
- Department of Pharmacokinetics and Pharmacodynammics and Global Center of Excellence (COE), School of Pharmaceutical Sciences, University of Shizuoka, Yada, Shizuoka 422-8526, Japan
| | - Naoki Orimoto
- Hanno Research Center, Taiho Pharmaceutical Co. Ltd., Misugidai, Hanno 357-8527, Japan
| | - Yasundo Yamasaki
- Hanno Research Center, Taiho Pharmaceutical Co. Ltd., Misugidai, Hanno 357-8527, Japan
| | - Mitsuhiro Arisawa
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| | - Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
| |
Collapse
|
47
|
Son JB, Kim SN, Kim NY, Hwang MH, Lee WS, Lee DH. Enantioselective Total Synthesis of (-)-Clavosolide A and B. B KOREAN CHEM SOC 2010. [DOI: 10.5012/bkcs.2010.31.03.653] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
48
|
Biffis A, Conte L, Tubaro C, Basato M, Aronica LA, Cuzzola A, Caporusso AM. Highly selective silylformylation of internal and functionalised alkynes with a cationic dirhodium(II) complex catalyst. J Organomet Chem 2010. [DOI: 10.1016/j.jorganchem.2009.12.018] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
49
|
Synthesis and structural and pharmacological properties of cyclopropane-based conformationally restricted analogs of 4-methylhistamine as histamine H3/H4 receptor ligands. Bioorg Med Chem 2010; 18:1076-82. [DOI: 10.1016/j.bmc.2009.12.046] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2009] [Revised: 12/16/2009] [Accepted: 12/17/2009] [Indexed: 11/21/2022]
|
50
|
Ren Z, Cao W, Tong W, Chen J, Wang C. Highly stereoselective synthesis of cyclopropyl heterocyclesviacyclopropanation of olefin with arsonium salt. J Heterocycl Chem 2009. [DOI: 10.1002/jhet.5570450105] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Zhongjiao Ren
- Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. China
| | - Weiguo Cao
- Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. China
- State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 200032, P. R. China
| | - Weiqi Tong
- Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. China
| | - Jie Chen
- Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. China
| | - Changqing Wang
- Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. China
| |
Collapse
|